EVENTIDE ASSET MANAGEMENT, LLC

Position in NRIX — Nurix Therapeutics, Inc.

CIK 1442891 Boston, MA

Position in NRIX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$31,486,884

+$11,369,543 QoQ

Shares Held

1,297,893

0.0% QoQ

Ownership

1.25%

of shares outstanding

% of Portfolio

0.42%

of 13F equity value

Holder Rank

#23

of 210 holders

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

EVENTIDE ASSET MANAGEMENT, LLC holds $1,774,593,873 across 55 Biotechnology names. NRIX ranks #24 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MIRM	Mirum Pharmaceuticals, Inc.	1,248,389	$146,148,900
2	ARGX	Argenx SE	125,668	$116,591,000
3	SRRK	Scholar Rock Holding Corp	2,111,410	$116,127,550
4	PCVX	Vaxcyte, Inc.	1,380,219	$80,232,130
5	AXSM	Axsome Therapeutics, Inc.	316,820	$77,548,031
6	RPRX	Royalty Pharma plc	1,380,261	$77,391,234
7	INSM	INSMED Inc	583,665	$62,230,362
8	BLTE	Belite Bio, Inc	390,829	$60,181,803

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$31,486,884	1,297,893	0.0%	Shares	Sole	2026-08-14
2026-03-31	$20,117,341	1,297,893	0.0%	Shares	Sole	2026-05-15
2025-12-31	$24,621,030	1,297,893	+12.5%	Shares	Sole	2026-02-13
2022-06-30	$14,621,180	1,154,000	-38.3%	Shares	Sole	2022-08-15
2022-03-31	$26,198,700	1,870,000	0.0%	Shares	Sole	2022-05-16
2021-12-31	$54,136,500	1,870,000	+55.8%	Shares	Sole	2022-02-14
2021-09-30	$35,952,000	1,200,000	0.0%	Shares	Sole	2021-11-15
2021-06-30	$31,836,000	1,200,000	0.0%	Shares	Sole	2021-08-16
2021-03-31	$37,308,000	1,200,000	+14.3%	Shares	Sole	2021-05-14
2020-12-31	$34,524,000	1,050,000	+111.0%	Shares	Sole	2021-02-16
2020-09-30	$17,376,103	497,740	—	Shares	Sole	2020-11-13
No filing history on record for this holder in this stock.